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ABSTRACT 
Allergic asthma is the major phenotype of asthma and is characterized by specific responses to 
allergens as well as airway hyperresponsiveness (AHR), inflammation and remodelling. Mast cells 
and airway smooth muscle cells (ASM) play an important role in the allergic airway response and 
there are several indications that a cross-talk exists between these two cell types contributing to 
asthma pathogenesis. However, these interactions and the mechanisms behind them are not fully 
understood. The overall aim of this thesis was to further elucidate the interactions between mast 
cells and ASM in different animal models of allergic asthma.  
 
When responses between wild-type and mast cell-deficient mice, with and without mast cell 
engraftment were compared, we found that AHR was both mast cell dependent and independent 
using the same chronic mouse model of asthma. Although pulmonary mast cell number, distribution 
and possibly prostanoid secretion influenced the severity and localisation of AHR and levels of 
specific-IgE, inflammatory cell infiltration and remodelling was unaffected. However, the mere 
presence of mast cells had an effect on the levels of interleukin 17 and 33 (IL-17 and IL-33), two 
cytokines that are associated with asthma. 
  
By studying airway responses in a guinea pig model of allergic asthma, we found that the early 
allergic reaction caused an altered airway resistance more similar to the response in humans than 
that seen in mice. This could be explained by the greater number and different distribution of mast 
cells, as well as the secretion of histamine and cysteinyl-leukotrienes from mast cells, suggesting 
that there are advantages to using guinea pigs compared to mice in asthma research.   
  
We continued by studying how IL-33 affected the early allergic reaction in a mouse model of 
allergic sensitisation. We found that intranasal IL-33 in sensitised mice increased the smooth muscle 
contraction in isolated airways from these mice when challenged with allergen ex vivo. The increase 
was mast cell and IL1RL1 (the receptor for IL-33) dependent and was mediated via an enhanced 
secretion of serotonin. The direct effects of IL-33 on mast cells to increase their production, storage 
and mediator release were confirmed in mast cell cultures. Finally, we observed that IL-33 increased 
airway resistance, in a mast cell- and serotonin-dependent fashion following allergen challenge in 
vivo. 
  
To further investigate how IL-33 influenced other features of allergic asthma, we studied the effects 
of IL-33 combined with an allergenic antigen on AHR, inflammation and remodelling in two 
different mouse models of asthma. No differences were observed when using a mast cell-
independent protocol of sensitisation and challenge. However, using a protocol that has been shown 
to induce mast cell-dependent AHR and inflammation in sensitised and challenged mice, IL-33 
combined with antigen elicited synergistic deleterious effects on AHR, inflammation and 
remodelling. 
  
The studies in this thesis emphasise the importance of choosing the appropriate animal model when 
studying allergic asthma. The findings herein support that pulmonary mast cell number and 
distribution affects lung function in the disease state. Finally, we have shown that release of IL-33 is 
increased during allergic inflammatory conditions, and the level of the increase is affected by mast 
cells. IL-33 worsens several characteristic features of allergic asthma including the early allergic 
reaction, AHR, inflammation and remodelling, for some features in a mast cell-dependent manner. 
In conclusion, we have highlighted the importance of IL-33 in conjunction with mast cells for 
asthma development and severity and have identified a potential new target for asthma therapy.  
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